14. 置放中央靜脈導管，導致血栓併發症的危險因子，下列何者為非？ (A) 置放超過6天 (B) 放夜間置放 (C) 置放多條靜脈導管 (D) 置放於鎖骨下靜脈

14. 置放中央靜脈導管，導致血栓併發症的危險因子，下列何者為非？
(A) 置放超過6天
(B) 放夜間置放
(C) 置放多條靜脈導管
(D) 置放於鎖骨下靜脈

答案：登入後查看
統計： A(0), B(1), C(0), D(1), E(0) #2824895

私人筆記 (共 1 筆)

2023/06/17

私人筆記#5216988

未解鎖

答: D 詳: 大部分study都提到D...

(共 366 字，隱藏中）

前往觀看

15. Concerning β-adrenergic agonists as used in the treatment of asthma, which of the following statements are TRUE? ( a ). The mechanism of action is through activation of adenyl-cyclase, increasing intracellular c-AMP. (b) Oral delivery of β-adrenergic agonists has a similar side effect profile to that of aerosol delivery. (c). Tachycardia due to selective β-2 agonists may be due to “crossover” with β-1 stimulation as well as a reflex response to peripheral vasodilatation. (d). Breath activated powder inhalers require more patient coordination than metered dose inhalers. (A) (a) + (b) (B) (a) + (c) (C) (a) + (b) + (d) (D) (b) + (c) + (d)

14. 置放中央靜脈導管，導致血栓併發症的危險因子，下列何者為非？
(A) 置放超過6天
(B) 放夜間置放
(C) 置放多條靜脈導管
(D) 置放於鎖骨下靜脈

私人筆記 (共 1 筆)

相關試題

相關試卷